Israeli drug is treating rare disease

OX1, a key drug compound that was developed by Dr. Daniel Chain while heading the Israeli company Mindset BioPharmaceuticals, protects nerve cells from highly oxidizing neurotoxins. OX1 is treating Friedreich’s Ataxia and may be used for other neuro-degenerative diseases.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *